全髋关节置换术后新型减少阿片类药物疼痛管理方案:对阿片消耗、疼痛严重程度及患者报告结局的影响
本研究为回顾性研究,比较全髋关节置换术后传统疼痛管理方案与减少阿片类药物方案。减少阿片组住院期间及出院后阿片消耗均显著低于传统组,疼痛评分变化率与患者报告结局无显著差异。作者认为减少阿片方案可减少阿片消耗并提供等效的疼痛管理和患者报告结局。
要点
- 减少阿片组住院期间阿片消耗显著低于传统组(14.6 ± 16.7 vs 25.7 ± 18.8 MME/d,P < .001)。
- 减少阿片组出院后阿片消耗显著低于传统组(13.9 ± 24.2 vs 80.1 ± 55.9 MME,P < .001)。
- 两组患者报告结局各时间点无显著差异(P > .05),疼痛评分变化率无显著差异(P = .463)。
核心结论
- 减少阿片类药物方案可减少全髋关节置换术后90天诊疗过程中的阿片消耗,并提供与传统阿片方案等效的疼痛管理和患者报告结局。
研究设计与样本
- 回顾性研究,比较全髋关节置换术后传统疼痛管理方案与减少阿片类药物疼痛管理方案实施前后的结局,患者分为传统方案组和减少阿片方案组。
主要发现
- 两组髋关节残疾与骨关节炎结局评分-关节置换版在各时间点均无统计学显著差异(P > .05)。
- 疼痛评分随时间显著下降(P < .01),但两种疼痛管理方案间各时间点变化率无统计学显著差异(P = .463)。
- 减少阿片组住院期间阿片消耗显著低于传统组(14.6 ± 16.7 vs 25.7 ± 18.8 MME/d,P < .001)。
- 减少阿片组出院后阿片消耗显著低于传统组(13.9 ± 24.2 vs 80.1 ± 55.9 MME,P < .001)。
临床怎么用
- 作者认为减少阿片类药物方案可能有助于降低术后阿片使用相关不良事件风险,并为临床实践提供减少阿片足迹的手段。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Opioid prescriptions and subsequent opioid-related deaths have increased substantially in the past several decades. Orthopedic surgery ranks among the highest of all specialties with respect to the amount of opioids prescribed. We present here the outcomes of our opioid-sparing pain management pilot protocol for total hip arthroplasty (THA). METHODS: A retrospective study was conducted to assess outcomes before and after the implementation of an opioid-sparing pain management protocol for THA. Patients were divided into 2 cohorts for comparison: (1) traditional pain management protocol and (2) opioid-sparing pain management protocol. The Hip Disability and Osteoarthritis Outcome Score for Joint Replacement, pain severity using a Visual Analog Scale, and inpatient morphine milligram equivalents (MMEs) per day were compared between the 2 cohorts. RESULTS: No statistically significant difference was observed in Hip Disability and Osteoarthritis Outcome Score for Joint Replacement between the 2 cohorts at any time point (P > .05). Although there was a significant decrease in pain scores over time (P < .01), there was no statistically significant difference in the rates of change between the 2 pain management protocols at any time point (P = .463). Inpatient opioid consumption was significantly lower for the opioid-sparing cohort in comparison to the traditional cohort (14.6 ± 16.7 vs 25.7 ± 18.8 MME/d, P < .001). Similarly, the opioid-sparing cohort received significantly less opioids than the traditional cohort during the post discharge period (13.9 ± 24.2 vs 80.1 ± 55.9 MME, P < .001). CONCLUSION: The results of this study suggest that an opioid-sparing protocol reduces opioid consumption and provides equivalent pain management and patient-reported outcomes during the 90-day THA episode of care relative to a traditional opioid-based regimen. These findings may help decrease the risk of adverse events associated with postoperative opioid use and provide a means of decreasing the opioid footprint in clinical practice.
引用
- Padilla JA, Gabor JA, Schwarzkopf R, et al. A Novel Opioid-Sparing Pain Management Protocol Following Total Hip Arthroplasty: Effects on Opioid Consumption, Pain Severity, and Patient-Reported Outcomes. J Arthroplasty. 2019. PMID: 31311667. doi:10.1016/j.arth.2019.06.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。